Emergency Medicine Doctors in Manhattan, KS Accepting Medicare

10 Emergency Medicine doctors found. Showing 1 - 10

Greg Hamel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-3322    Fax: 785-565-4754

Dr. Tamara Jo Burke-moree, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-2800    Fax: 785-565-4754

Sylvia Julie Tschernyavsky, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-2800    Fax: 785-565-4754

Jocelyn Elizabeth Mattoon, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Research Park Dr, Manhattan, KS 66502 Phone: 785-537-2651

Douglas M Harper, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-3322    Fax: 785-565-4754

James Gardner, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 College Ave Ste D200, Manhattan, KS 66502 Phone: 785-537-4940    Fax: 785-537-0836

Dr. Todd M Crane, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-587-4280

Ms. Breanne Louise Burks, Emergency Medicine - Sports Medicine Medicare: Not Enrolled in Medicare Practice Location: 1129 Claflin Rd, Manhattan, KS 66502 Phone: 816-383-1410

Dr. Jeremy Jon Bennett, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-2800    Fax: 785-565-4754

Catherine O'keefe, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1823 College Ave, Manhattan, KS 66502 Phone: 785-776-3322    Fax: 785-565-4754

News Archive

Dihydroartemisinin-piperaquine more effective than artemether-lumefantrine in treating malaria

'Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine' concludes a systematic review published by the Cochrane Infectious Disease Group, hosted by LSTM.

Health experts in the UK warn flu vaccine will run out

Fear of a flu pandemic has triggered an unprecedented demand for winter flu vaccines and health officials in the UK are warning that the NHS could run out of supplies.

Iksuda Therapeutics closes $47 million financing round

Iksuda Therapeutics (Iksuda) has announced it has completed a US $47 million (circa GB £34 million) financing round, co-led by Mirae Asset Capital and its subsidiaries, Celltrion and Premier Partners, with the Company being advised by Ashfords LLP. The funding will support the advancement of Iksuda's lead ADC assets and expansion of its payload and conjugation platform technologies.

Diamyd Medical reports first quarter group total net sales of MSEK 144.5

Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.

Read more Medical News

› Verified 5 days ago